163 related articles for article (PubMed ID: 7715225)
21. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
22. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
23. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
[TBL] [Abstract][Full Text] [Related]
24. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
[TBL] [Abstract][Full Text] [Related]
25. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
Poon MC; Hurst RE; Rives MS
Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
[TBL] [Abstract][Full Text] [Related]
26. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass.
Spanier TB; Chen JM; Oz MC; Edwards NM; Kisiel W; Stern DM; Rose EA; Schmidt AM
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):860-9. PubMed ID: 9806393
[TBL] [Abstract][Full Text] [Related]
27. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
[TBL] [Abstract][Full Text] [Related]
28. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery.
Grieshaber P; Bakchoul T; Wilhelm J; Wagner A; Wollbrück M; Böning A; Sachs U
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons.
Bel A; Borik W; Davidson S; Helies JM; Stimmer L; Fremes S; Zelenkofske S; Rusconi C; Alexander J; Alexander D; Menasché P; Pepper J
Eur J Cardiothorac Surg; 2016 Feb; 49(2):682-9. PubMed ID: 25953802
[TBL] [Abstract][Full Text] [Related]
30. Neutralization of heparin activity.
Pai M; Crowther MA
Handb Exp Pharmacol; 2012; (207):265-77. PubMed ID: 22566228
[TBL] [Abstract][Full Text] [Related]
31. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
[TBL] [Abstract][Full Text] [Related]
32. Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.
Sasaki E; Minamiguchi K; Kitazato KT; Nagase H; Kitazato K
Haemostasis; 1997; 27(4):174-83. PubMed ID: 9483172
[TBL] [Abstract][Full Text] [Related]
33. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
Bode AP; Castellani WJ; Hodges ED; Yelverton S
Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
[TBL] [Abstract][Full Text] [Related]
34. Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons.
Hiramatsu Y; Gikakis N; Anderson HL; Gorman JH; Marcinkiewicz C; Gould RJ; Niewiarowski S; Edmunds LH
J Thorac Cardiovasc Surg; 1997 Jan; 113(1):182-93. PubMed ID: 9011688
[TBL] [Abstract][Full Text] [Related]
35. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept.
Rochon AG; Bélisle S; Couture P; Fortier A; Lebon JS; Deschamps A
J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2369-2374. PubMed ID: 32014311
[TBL] [Abstract][Full Text] [Related]
37. Influence of platelet factor 4 on the neutralization of heparin by protamine.
Shanberge JN; Quattrociocchi-Longe TM
Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
[TBL] [Abstract][Full Text] [Related]
38. Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis.
Silver PJ; Broughton R; Bouthillier J; Quinn TA; Wallace AM; Weishaar RE
Thromb Res; 1998 Aug; 91(3):143-50. PubMed ID: 9733158
[TBL] [Abstract][Full Text] [Related]
39. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
[TBL] [Abstract][Full Text] [Related]
40. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
Nielsen VG
Ann Thorac Surg; 2006 May; 81(5):1720-7. PubMed ID: 16631662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
